SOTROVIMAB FOR INJECTION
SOTROVIMAB FOR INJECTION
Authorization By Interim Order Revoked
DIN Number
02518341
Drug Class
Human
Market Date
Oct 8, 2021
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02518341
AIG Number0163072001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
COVID-19 - IO - Authorization
,
Prescription
A
ATC Code
J06BD05 SOTROVIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification08:18.24
Health Canada Classification
ACTIVE INGREDIENTS (1)
SOTROVIMABActive
Strength: 500 MG / 8 ML
Monograph: SOTROVIMAB